From the Guidelines
Elevated Hemoglobin A1c (HbA1c) indicates higher-than-normal blood glucose levels over the past 2-3 months, with normal HbA1c below 5.7%, prediabetes ranging from 5.7% to 6.4%, and diabetes diagnosed at 6.5% or higher, as supported by the most recent study 1.
Importance of HbA1c
The HbA1c test is a crucial measure of average glucose control, providing valuable information about blood glucose levels over an extended period. It is essential for assessing the risk of diabetes complications, such as heart disease, kidney damage, vision problems, and neuropathy.
Limitations of HbA1c
However, HbA1c has limitations, including the lack of information about acute glycemic excursions and the acute complications of hypo- and hyperglycemia, as well as potential confounding conditions such as anemia, hemoglobinopathies, iron deficiency, and pregnancy 1.
Clinical Recommendations
For nonpregnant adults, a reasonable HbA1c goal is less than 7%, although more stringent goals (such as <6.5%) may be appropriate for selected individuals, and less stringent goals (such as <8%) may be suitable for patients with a history of severe hypoglycemia or limited life expectancy 1.
Monitoring and Treatment
Regular monitoring of blood glucose levels is essential, and HbA1c should be rechecked every 3-6 months to assess treatment effectiveness. Treatment depends on the level of elevation and may include lifestyle modifications, such as improved diet, regular exercise, weight management, and stress reduction, as well as medication, including metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, or insulin therapy 1.
Key Points
- Elevated HbA1c is concerning due to the risk of sustained high blood glucose damaging blood vessels and nerves.
- The HbA1c test reflects average glucose control over 2-3 months.
- Regular monitoring and treatment are crucial to prevent diabetes complications.
- Lifestyle modifications and medication may be necessary to manage elevated HbA1c levels.
From the Research
Definition of Elevated Hemoglobin A1c (HbA1c)
Elevated Hemoglobin A1c (HbA1c) is an indicator of poor glycemic control, representing average blood glucose levels over a period of 2-3 months 2.
Indicators of Glycemic Control
- HbA1c is considered the gold standard for assessing glycemic control, with values above the recommended range indicating poor control 3.
- Glycated albumin (GA) and 1,5-anhydroglucitol (1,5-AG) are other indicators of glycemic control, with GA reflecting 2-week glycemia and 1,5-AG indicating rapid changes in hyperglycemia 2.
- Fasting blood sugar (FBS) has been investigated as an alternative indicator of long-term diabetic control, with a moderate and significant positive correlation between FBS and estimated average blood glucose (eAG) derived from HbA1c 4.
Complications Associated with Elevated HbA1c
- Elevated HbA1c levels have been linked to an increased risk of microvascular and macrovascular complications, severe hypoglycemia, and mortality in patients with type 2 diabetes 3.
- Metabolomics profiles associated with HbA1c levels have identified significant differences in serum metabolites between patients with normal and high HbA1c levels, providing insight into the mechanisms underlying changes in HbA1c levels 5.
- Elevated HbA1c levels have also been associated with an increased risk of postoperative complications, including infections, impaired wound healing, and cardiovascular events, particularly in patients undergoing joint replacement surgery 6.
HbA1c Target Ranges
- The recommended HbA1c target ranges vary depending on the patient's health status, with ranges of 7% to <7.5% for those in good health, 7.5% to <8% for those in intermediate health, and 8% to <8.5% for those in poor health 3.